| 注册
首页|期刊导航|重庆医学|复方盐酸吡格列酮格列美脲片与格列美脲片治疗2型糖尿病的疗效与安全性对照研究

复方盐酸吡格列酮格列美脲片与格列美脲片治疗2型糖尿病的疗效与安全性对照研究

蒲丹岚 尹经霞 谢洁 杨刚毅 廖涌

重庆医学2018,Vol.47Issue(7):915-918,4.
重庆医学2018,Vol.47Issue(7):915-918,4.DOI:10.3969/j.issn.1671-8348.2018.07.015

复方盐酸吡格列酮格列美脲片与格列美脲片治疗2型糖尿病的疗效与安全性对照研究

Comparative study of efficacy and safety of compound pioglitazone hydrochloride glimepiride tablet and glimepiride tablet in treating type 2 diabetes mellitus

蒲丹岚 1尹经霞 2谢洁 2杨刚毅 3廖涌1

作者信息

  • 1. 重庆市巴南区人民医院内分泌科 401320
  • 2. 武警重庆总队医院内分泌科,重庆400061
  • 3. 重庆医科大学附属第二医院内分泌科 400010
  • 折叠

摘要

Abstract

Objective To compare the efficacy and safety of compound pioglitazone hydrochloririe glimepiride tablet and glimepiride tablet in the treatment of type 2 diabetic mellitus(T2DM) for evaluating the effectiveness and safety of compound pioglitazone hydrochloride glimepiride tablet for treating T2DM.Methods The random,double-blind,double-dummy,positive drugs parallel control clinical study method was adopted.Thirty-three T2DM patients with poorly controlled blood glucose were randomly assigned to the test group(n=22) and control group(n=11) by the 2 ∶ 1 ratio.The test group was given compound pioglitazone hydrochloride glimepiride tablet,while the control group received glimepiride tablet.The treatment cycle was 12 weeks.The differences of FBG,HbA1c,FINS and HOMA-IR in the two groups were compared between before and after treatment.Moreover the changes of body mass,blood pressure and blood lipids as well as adverse events occurrence were compared between the two groups.Results Thirty-one cases finished the treatment follow up(21 cases in the test group and 10 cases in the control group);the decreased amplitudes of HbA1c levels after 12-week treatment in the test group and control group were (0.99 ± 1.87)% and (-0.02 ± 0.90) % respectively,which of FPG were (0.94 ± 1.87) mmol/L and (0.37 ± 2.62) mmol/L respectively.The FPG and HbA1c levels after treatment in the test group were decreased compared with before treatment,the difference was statistically significant (P<0.01).The change difference of FPG and HbA1c in the control group had no statistical difference(P>0.05).FINS and HOMO-IR in the test group were significantly decreased before and after treatment,the difference was statistically significant (P<0.01).The incidence rate of hypoglycemia had no statistically significant difference between the test group and control group.Conclusion The effectiveness of compound pioglitazone hydrochloride glimepiride tablet in treating T2 DM is superior to the single use of glimepiride,while the safety is equivalent to single use of glimepiride.

关键词

2型糖尿病/有效性研究/复方盐酸吡格列酮格列美脲片/安全性

Key words

type 2 diabetes mellitus/effectiveness study/compound pioglitazone hydrochloride glimepiride tablet/security

分类

医药卫生

引用本文复制引用

蒲丹岚,尹经霞,谢洁,杨刚毅,廖涌..复方盐酸吡格列酮格列美脲片与格列美脲片治疗2型糖尿病的疗效与安全性对照研究[J].重庆医学,2018,47(7):915-918,4.

基金项目

重庆市卫计委2016医学科研计划项目(2016MSXM212) (2016MSXM212)

重庆市南岸区科技攻关计划项目(20111723). (20111723)

重庆医学

OACSTPCD

1671-8348

访问量1
|
下载量0
段落导航相关论文